← Encyclopedia Anti-Aging, Longevity, and Cellular Health

Humanin

🔹 What is Humanin?

Class: Mitochondrial-derived peptide (MDP), first identified in the hypothalamus. Mechanism:

  • Protects mitochondria from oxidative stress, helping preserve cellular energy output.
  • Modulates cellular stress and inflammatory signaling pathways implicated in neurodegeneration.
  • Associated in research with extended cellular lifespan and reduced age-related cellular damage.

Primary focus:

  • Cellular longevity and protection against age-related decline.
  • Neuroprotection, with exploratory interest in Alzheimer’s and Parkinson’s contexts.
  • Cardiovascular tissue protection through reduced oxidative damage and inflammation.

🔹 Oral Dosage Range:

  • Available in capsule form, though oral bioavailability is considerably lower than injectable delivery.

Notes: Oral use is more of a convenience option than a reliable way to achieve meaningful systemic exposure.


🔹 Injectable / Subcutaneous Dosage (most common for research use) Range:

  • Typically 100–500 mcg per week, adjusted based on the specific longevity or neuroprotective goal.

Frequency:

  • Weekly dosing is the most commonly referenced schedule, sometimes split across the week.

Rationale: Subcutaneous delivery bypasses the bioavailability issues seen with oral administration, making it the preferred route when meaningful systemic exposure is the goal.


🔹 Cycle Length Common cycle length: Often used in extended cycles given its longevity/cellular-health focus rather than short acute courses. Off-cycle: Periodic reassessment is reasonable given how early-stage the human evidence base is.


🔹 Optimal Dosing Window

  • No strong circadian rationale established; weekly consistency matters more than specific timing.

Educational Integration Example (injectable / subcutaneous)

  • Example protocol: 200 mcg subcutaneous 1–2 times weekly as part of a broader longevity-focused stack.
  • Frequently discussed alongside other mitochondrial and cellular-health-focused compounds.

🔹 Stacking Strategy (Educational / Complementary) Since Humanin’s core value proposition is mitochondrial protection and cellular longevity, complementary stacks tend to focus on energy metabolism and antioxidant defense: 🔸 Mitochondrial & Longevity Support:

  • NAD⁺ precursors (NMN, NR): Support the same mitochondrial energy pathways Humanin helps protect.
  • CoQ10, PQQ: Mitochondrial cofactors that complement Humanin’s protective action.

🔸 Neuroprotective & Antioxidant Support:

  • Glutathione: Antioxidant support that reinforces Humanin’s role in reducing oxidative cellular damage.
  • Epitalon: Cellular longevity peptide that pairs conceptually with Humanin’s anti-aging focus.

Rationale: Humanin protects the cell’s energy infrastructure; stacking aims to reinforce mitochondrial resilience and reduce oxidative burden rather than duplicate its specific mechanism.

Studied in Humans? Limited — much of the evidence base is preclinical or early-stage, with human data still emerging.

FDA Approved? No

Allowed for 503a Compounding Pharmacy? No

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.